BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17267035)

  • 21. Triggering of apoptosis by Puma is determined by the threshold set by prosurvival Bcl-2 family proteins.
    Callus BA; Moujallad DM; Silke J; Gerl R; Jabbour AM; Ekert PG; Vaux DL
    J Mol Biol; 2008 Dec; 384(2):313-23. PubMed ID: 18835564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid pathogen-induced apoptosis: a mechanism used by dendritic cells to limit intracellular replication of Legionella pneumophila.
    Nogueira CV; Lindsten T; Jamieson AM; Case CL; Shin S; Thompson CB; Roy CR
    PLoS Pathog; 2009 Jun; 5(6):e1000478. PubMed ID: 19521510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study.
    Dillon SM; Friedlander LJ; Rogers LM; Meditz AL; Folkvord JM; Connick E; McCarter MD; Wilson CC
    J Virol; 2011 Jan; 85(1):397-409. PubMed ID: 20962079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical assessment of apoptosis-associated proteins: p53, Bcl-xL, Bax and Bak in gastric cancer cells in correlation with clinical and pathomorphological factors.
    Gryko M; Pryczynicz A; Guzińska-Ustymowicz K; Kamocki Z; Zaręba K; Kemona A; Kędra B
    Adv Med Sci; 2012 Jun; 57(1):77-83. PubMed ID: 22440942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory compound lipopolysaccharide promotes the survival of GM-CSF cultured dendritic cell via PI3 kinase-dependent upregulation of Bcl-x.
    Chen S; Li X; Zhang W; Zi M; Xu Y
    Immunol Cell Biol; 2018 Oct; 96(9):912-921. PubMed ID: 29624724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel checkpoint in the Bcl-2-regulated apoptotic pathway revealed by murine cytomegalovirus infection of dendritic cells.
    Andoniou CE; Andrews DM; Manzur M; Ricciardi-Castagnoli P; Degli-Esposti MA
    J Cell Biol; 2004 Sep; 166(6):827-37. PubMed ID: 15353550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells.
    Illario M; Giardino-Torchia ML; Sankar U; Ribar TJ; Galgani M; Vitiello L; Masci AM; Bertani FR; Ciaglia E; Astone D; Maulucci G; Cavallo A; Vitale M; Cimini V; Pastore L; Means AR; Rossi G; Racioppi L
    Blood; 2008 Jan; 111(2):723-31. PubMed ID: 17909078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity.
    Chen M; Huang L; Wang J
    Blood; 2007 May; 109(10):4360-7. PubMed ID: 17227827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice.
    Pirtskhalaishvili G; Shurin GV; Gambotto A; Esche C; Wahl M; Yurkovetsky ZR; Robbins PD; Shurin MR
    J Immunol; 2000 Aug; 165(4):1956-64. PubMed ID: 10925278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-10 restricts dendritic cell (DC) growth at the monocyte-to-monocyte-derived DC interface by disrupting anti-apoptotic and cytoprotective autophagic molecular machinery.
    Martin C; Espaillat MP; Santiago-Schwarz F
    Immunol Res; 2015 Dec; 63(1-3):131-43. PubMed ID: 26395023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. bcl-xL is critical for dendritic cell survival in vivo.
    Hon H; Rucker EB; Hennighausen L; Jacob J
    J Immunol; 2004 Oct; 173(7):4425-32. PubMed ID: 15383573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cleavage of anti-apoptotic Bcl-2 family members after TCR stimulation contributes to the decision between T cell activation and apoptosis.
    Guerrero AD; Welschhans RL; Chen M; Wang J
    J Immunol; 2013 Jan; 190(1):168-73. PubMed ID: 23203923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of PUMA (BBC3) does not prevent thrombocytopenia caused by the loss of BCL-XL (BCL2L1).
    Delbridge AR; Chappaz S; Ritchie ME; Kile BT; Strasser A; Grabow S
    Br J Haematol; 2016 Sep; 174(6):962-9. PubMed ID: 27221652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The life and death of immune cell types: the role of BCL-2 anti-apoptotic molecules.
    Carrington EM; Tarlinton DM; Gray DH; Huntington ND; Zhan Y; Lew AM
    Immunol Cell Biol; 2017 Nov; 95(10):870-877. PubMed ID: 28875977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid leukemia factor 1 interfered with Bcl-XL to promote apoptosis and its function was regulated by 14-3-3.
    Sun Y; Fu A; Xu W; Chao JR; Moshiach S; Morris SW
    J Physiol Biochem; 2015 Dec; 71(4):807-21. PubMed ID: 26563351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-1BB protects dendritic cells from prostate cancer-induced apoptosis.
    Youlin K; Jianwei Z; Xin G; Li Z; Xiaodong W; Xiuheng L; Hengchen Z; Zhiyuan C
    Pathol Oncol Res; 2013 Apr; 19(2):177-81. PubMed ID: 23070584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways.
    Wang JC; Felizardo TC; Au BC; Fowler DH; Dekaban GA; Medin JA
    Virol J; 2013 Jul; 10():240. PubMed ID: 23870437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-XL and Bcl-2 repress a common pathway of cell death.
    Chao DT; Linette GP; Boise LH; White LS; Thompson CB; Korsmeyer SJ
    J Exp Med; 1995 Sep; 182(3):821-8. PubMed ID: 7650488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic cells during mousepox: The role of delayed apoptosis in the pathogenesis of infection.
    Orlowski P; Pardecka M; Cymerys J; Krzyzowska M
    Microb Pathog; 2017 Aug; 109():99-109. PubMed ID: 28554653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-2, Bcl-xL and c-FLIP(L) potentially regulate the susceptibility of human peripheral blood monocyte-derived dendritic cells to cell death at different developmental stages.
    Hasebe H; Sato K; Yanagie H; Takeda Y; Nonaka Y; Takahashi TA; Eriguchi M; Nagawa H
    Biomed Pharmacother; 2002 May; 56(3):144-51. PubMed ID: 12046686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.